A prospective study of quality of life in 77 type 1 diabetic patients 12 months after a hospital therapeutic educational programme

Debaty, I.; Halimi, Serge; Quesada, Javier Luna; Baudrant, Magalie; Allenet, Benoît; Py, Benhamou

doi:10.1016/j.diabet.2008.03.007

Cited by 11 publications

(11 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For example, in a large review paper Rubin and Peyrot 24 reported that better glycaemic control is associated with better quality of life, however, such a relationship was not found by Redekop and colleagues when they controlled for other factors in multivariate analysis 25 . Specifically examining the impact of therapeutic education on quality of life, Debaty and colleagues 26 found that among a group on adults with type 1 diabetes, those with poorer glycaemic control before the programme appeared to derive greater benefit from therapeutic education.…”

Section: Discussionmentioning

confidence: 99%

Predictors of quality of life gains among people with type 1 diabetes participating in the Dose Adjustment for Normal Eating (DAFNE) structured education programme

Byrne

Coffey

Hara

et al. 2012

Diabetes Research and Clinical Practice

View full text Add to dashboard Cite

Aims: To examine predictors of quality of life gains among people with type 1 diabetes following DAFNE (Dose Adjustment for Normal Eating) self-management training programme.Methods: Clinical and questionnaire data were collected from 437 patients from 6 hospital centres before, and at 18 month post, DAFNE intervention. Glycated haemoglobin (HbA 1c ), weight and height, and blood pressure levels were recorded by clinicians during clinic appointments. Questionnaires included the Diabetes-Specific Quality of Life Scale (DSQOLS), the Problem Areas in Diabetes Scale (PAID) and the Hospital Anxiety and Depression Scale (HADS). Basic demographics were recorded at baseline. Linear mixed models were fitted to identify predictors of change in quality of life at 18 month follow up.Results: Those with high levels of diabetes-related distress experienced greatest improvement in DSQOLS quality of life scores (p=0.001). Those with poor glycaemic control (higher levels of HbA 1c ; p=0.03) and those with high levels of anxiety (p=0.001) experienced greatest reductions in diabetes-related distress.Conclusions: Those with higher baseline levels of anxiety, higher levels of diabetes-related distress and higher baseline levels of HbA 1c are most likely to experience quality of life gain from participation in self-management programmes like DAFNE.

show abstract

Section: Discussionmentioning

confidence: 99%

Predictors of quality of life gains among people with type 1 diabetes participating in the Dose Adjustment for Normal Eating (DAFNE) structured education programme

Byrne

Coffey

Hara

et al. 2012

Diabetes Research and Clinical Practice

View full text Add to dashboard Cite

show abstract

“…Studies have shown that proper management of diabetes by the patient had a major role in the prevention of complications (10). Debaty states that patients' involvement is essential for successful treatment (7). Thus, one of the most important activities to control the disease is training program, as an integral part of diabetes management (11).…”

Section: Introductionmentioning

confidence: 99%

“…Although this chronic disease is not fatal, it can cause permanent disability (5) or serious complications such as blindness, lower limb amputation, and kidney and heart diseases (6). As many chronic diseases, diabetes also requires daily treatment for life long, hence it significant affects the quality of life (7). Due to increasing prevalence of diabetes and high costs, effective interventions to control symptoms of the disease and quality of life of patients seems to be necessary (8).…”

Section: Introductionmentioning

confidence: 99%

Comparison of Effectiveness of Self-Empowerment Through Educational Package and Workshop in Quality of Life of Diabetic Patients

Nabiamjad

Rasouli

Mohammadpour

et al. 2016

Jundishapur J Chronic Dis Care

View full text Add to dashboard Cite

Background: Diabetes mellitus, as a chronic disease, largely affects lifestyle and quality of life. Education could affect quality of life of diabetic patient, however the results of studies have shown traditional and modern methods of education have various effects. Objectives: The aim of this study was to compare the effect of self-empowerment program through educational package and workshop on quality of life among diabetic patients. Methods: This study was a randomized clinical trial. Diabetic patients referring to the diabetes center, affiliated to Urmia University of Medical Sciences, participated in this study. A sample of 40 subjects was selected and they were divided into two groups of 20. A two-part questionnaire was used to collect data. The first part related to demographic information and the second was to assess the quality of life of diabetic patients, using audit of diabetes -dependent quality of life questionnaire.

show abstract

“…However, some patients have social, cultural, and educational limitations that may decrease compliance to treatment (Kahlili et al, 2016; Braga de Souza, et al, 2015;Jimmy, Jose, 2011). Thus, diabetes education and continued patient follow-up are central to increasing knowledge of the disease and treatment, developing self-care skills, and reducing and maintaining glycemic levels as established by the ADA, all of which have a positive effect on QoL perception (Brasil, 2013; Falconier et al, 2009;Debaty et al, 2008).In this context, diabetic patients' QoL is influenced by factors such as age, sex, obesity, comorbidities, complications, knowledge regarding DM, type of treatment, and glycemic control. The Health-Related Quality of Life (HRQoL) has been used to evaluate the impact of diabetes and its treatment on patient humanistic outcomes as it relates health, not to the absence of disease, but as complete physical; mental; and social well-being (Braga de Souza et al, 2015;Trento et al, 2013; Falconier et al, 2009;Debaty et al, 2008;Cases et al, 2003; HSGCD, 2001;Testa, Simonson, 1996).…”

mentioning

confidence: 99%

“…Thus, diabetes education and continued patient follow-up are central to increasing knowledge of the disease and treatment, developing self-care skills, and reducing and maintaining glycemic levels as established by the ADA, all of which have a positive effect on QoL perception (Brasil, 2013; Falconier et al, 2009;Debaty et al, 2008).…”

mentioning

confidence: 99%

Quality of life perception of type 1 diabetic patients treated with insulin analogs and receiving medication review with follow-up in a public health care service from Ponta Grossa-PR, Brazil

Garabeli

Daher

Wiens

et al. 2016

Braz. J. Pharm. Sci.

View full text Add to dashboard Cite

Glycemic control in patients with diabetes mellitus type 1 (DM1) reduces the risk of complications but requires a rigorous health care routine. Thus, diabetes education is central to increasing treatment compliance and self-care practices. This study aimed to evaluate the quality of life (QoL) and glycemic control of DM1 patients being treated with insulin analogs and receiving medication review with followup. This was a transversal study that included 110 patients registered at the 3 rd Health Regional of Ponta Grossa-PR, aged ≥ 18 years, and receiving pharmaceutical care for at least 1 year. The Diabetes Quality of Life Measure (DQOL)-Brazil was used to evaluate QoL. The data were statistically analyzed using SPSS version 17.0 with 95% confidence levels. Of the 110 patients, 58.2% were women. The average age was 33.7 years (±10.5), and the average glycated hemoglobin (HbA1c) value was 8% (±1.4). The mean total DQOL-Brazil score was 2.11 (95% confidence interval, 2.02 -2.21). All DQOL-Brazil scores were lower in patients with HbA1c ≤ 8%, indicating a better QoL. Good glycemic control, thus, appears to have a positive influence on the QoL, and pharmaceutical interventions are able to contribute to the achievement of therapeutic targets.Uniterms: Diabetes mellitus type 1/treatment. Diabetes mellitus type 1/treatment/quality of life. Pharmaceutical care. Insulin analogs. Pharmacotherapy follow-up. INTRODUCTIONDiabetes mellitus (DM) is a group of metabolic d i s o r d e r s p r i m a r i l y c h a r a c t e r i z e d b y c h r o n i c hyperglycemia. High glycemic levels are associated with micro-and macrovascular complications leading to damage to, and failure of organs such as the eyes (retinopathy), kidneys (nephropathy), nerves (neuropathy), heart, and blood vessels (ADA, 2016; Braga de Souza et al., 2015;Gross et al., 2002).According to the Diabetes Control and Complications Trial (DCCT), the risk of developing chronic complications is higher in patients with chronically high glycated hemoglobin (HbA1c) levels, and the risk gradually increases with HbA1c levels greater than 7% (Pimazoni Netto et al., 2009). The American Diabetes Association (ADA) defines an HbA1c value < 7% as the acceptable limit for diabetes control. With good glycemic control, patients can be symptom-free, and prevent acute and chronic complications (ADA, 2016;UKPDS, 1999;DCCT, 1988).DM is a chronic condition that requires daily self-care throughout life and has a negative impact on the subjective perception of the quality of life (QoL). However, daily treatment is fundamental to DM control and decreases the risk of complications (Debaty et al., 2008;Wood-Dauphinee, 1999). DM1 therapy includes intensive care demands such as daily blood glucose monitoring, multiple insulin injections, and specific dietary and physical activity recommendations (ADA, 2016). Not understanding all these recommendations and a lack of compliance to treatment leads to a poor glycemic control that can cause severe hyper-or hypoglycemia episodes and chronic complicat...

show abstract

A prospective study of quality of life in 77 type 1 diabetic patients 12 months after a hospital therapeutic educational programme

Cited by 11 publications

References 17 publications

Predictors of quality of life gains among people with type 1 diabetes participating in the Dose Adjustment for Normal Eating (DAFNE) structured education programme

Predictors of quality of life gains among people with type 1 diabetes participating in the Dose Adjustment for Normal Eating (DAFNE) structured education programme

Comparison of Effectiveness of Self-Empowerment Through Educational Package and Workshop in Quality of Life of Diabetic Patients

Quality of life perception of type 1 diabetic patients treated with insulin analogs and receiving medication review with follow-up in a public health care service from Ponta Grossa-PR, Brazil

Contact Info

Product

Resources

About